T CELL RECEPTORS RECOGNIZING MUTATED P53 Read more about T CELL RECEPTORS RECOGNIZING MUTATED P53 France18780006.5Filed on 2018-09-17
T CELL RECEPTORS RECOGNIZING MUTATED P53 Read more about T CELL RECEPTORS RECOGNIZING MUTATED P53 Finland18780006.5Filed on 2018-09-17
T CELL RECEPTORS RECOGNIZING MUTATED P53 Read more about T CELL RECEPTORS RECOGNIZING MUTATED P53 Spain18780006.5Filed on 2018-09-17
RECEPTOR TYROSINE KINASE INHIBITORS FOR TREATMENT OF PROTEIN KINASE MODULATION-RESPONSIVE DISEASE OR DISORDER Read more about RECEPTOR TYROSINE KINASE INHIBITORS FOR TREATMENT OF PROTEIN KINASE MODULATION-RESPONSIVE DISEASE OR DISORDER US Application 19/381,783Filed on 2025-11-06
Glypican 2 As A Cancer Marker And Therapeutic Target Read more about Glypican 2 As A Cancer Marker And Therapeutic Target Australia2023278110Filed on 2023-12-08
ZIRCONIUM-89 OXINE COMPLEX AS A CELL LABELING AGENT FOR POSITRON EMISSION TOMOGRAPHY Read more about ZIRCONIUM-89 OXINE COMPLEX AS A CELL LABELING AGENT FOR POSITRON EMISSION TOMOGRAPHY US Application 19/356,663Filed on 2025-10-13
METHOD OF SELECTING T CELLS WITH IMPROVED ANTI-CANCER ACTIVITY Read more about METHOD OF SELECTING T CELLS WITH IMPROVED ANTI-CANCER ACTIVITY European Patent21801948.7Filed on 2023-06-05
METHOD OF SELECTING T CELLS WITH IMPROVED ANTI-CANCER ACTIVITY Read more about METHOD OF SELECTING T CELLS WITH IMPROVED ANTI-CANCER ACTIVITY China202180089310.3Filed on 2023-07-05
METHOD OF SELECTING T CELLS WITH IMPROVED ANTI-CANCER ACTIVITY Read more about METHOD OF SELECTING T CELLS WITH IMPROVED ANTI-CANCER ACTIVITY Japan2023-550709Filed on 2023-05-08
SINGLE DOMAIN ANTIBODIES THAT SPECIFICALLY BIND THE S2 SUBUNIT OF SARS-COV-2 SPIKE PROTEIN AND COMPOSITIONS AND USES THEREOF Read more about SINGLE DOMAIN ANTIBODIES THAT SPECIFICALLY BIND THE S2 SUBUNIT OF SARS-COV-2 SPIKE PROTEIN AND COMPOSITIONS AND USES THEREOF US Application 19/482,967Filed on 2025-11-10